Literature DB >> 3606580

Plasmid-mediated trimethoprim-resistance in Staphylococcus aureus. Characterization of the first gram-positive plasmid dihydrofolate reductase (type S1).

H K Young, R A Skurray, S G Amyes.   

Abstract

The trimethoprim-resistance gene located on plasmid pSK1, originally identified in a multi-resistant Staphylococcus aureus from Australia, encodes the production of a dihydrofolate reductase (type S1), which confers a high degree of resistance to its host and is quite unlike any plasmid-encoded dihydrofolate reductase hitherto described. It has a low Mr (19,700) and has a higher specific activity than the constitutive Gram-negative plasmid dihydrofolate reductases. The type S1 enzyme is heat-stable and has a relatively low affinity for the substrate, dihydrofolate (Km 10.8 microM). It is moderately resistant to trimethoprim, and is competitively inhibited by this drug with an inhibitor-binding constant of 11.6 microM. This is the first identification and characterization of a plasmid-encoded trimethoprim-resistant dihydrofolate reductase derived from a Gram-positive species.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3606580      PMCID: PMC1147852          DOI: 10.1042/bj2430309

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Two distinct types of trimethoprim-resistant dihydrofolate reductase specified by R-plasmids of different compatibility groups.

Authors:  K H Pattishall; J Acar; J J Burchall; F W Goldstein; R J Harvey
Journal:  J Biol Chem       Date:  1977-04-10       Impact factor: 5.157

2.  Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.

Authors:  A C Chang; S N Cohen
Journal:  J Bacteriol       Date:  1978-06       Impact factor: 3.490

3.  R-factor mediated dihydrofolate reductases which confer trimethoprim resistance.

Authors:  S G Amyes; J T Smith
Journal:  J Gen Microbiol       Date:  1978-08

4.  The purification and properties of the trimethoprim-resistant dihydrofolate reductase mediated by the R-factor, R388.

Authors:  S G Amyes; J T Smith
Journal:  Eur J Biochem       Date:  1976-01-15

5.  Trimethoprim resistance plasmids of different origin encode different drug-resistant dihydrofolate reductases.

Authors:  B Tennhammar-Ekman; O Sköld
Journal:  Plasmid       Date:  1979-07       Impact factor: 3.466

6.  R-factor trimethoprim resistance mechanism: an insusceptible target site.

Authors:  S G Amyes; J T Smith
Journal:  Biochem Biophys Res Commun       Date:  1974-05-20       Impact factor: 3.575

7.  Inhibitor binding analysis of dihydrofolate reductases from various species.

Authors:  J J Burchall; G H Hitchings
Journal:  Mol Pharmacol       Date:  1965-09       Impact factor: 4.436

8.  Protein expression in Escherichia coli minicells containing recombinant plasmids specifying trimethoprim-resistant dihydrofolate reductases.

Authors:  M E Fling; L P Elwell
Journal:  J Bacteriol       Date:  1980-02       Impact factor: 3.490

9.  Trimethoprim-sensitivity testing and thymineless mutants.

Authors:  S G Amyes; J T Smith
Journal:  J Med Microbiol       Date:  1974-05       Impact factor: 2.472

10.  R plasmid dihydrofolate reductase with subunit structure.

Authors:  S L Smith; D Stone; P Novak; D P Baccanari; J J Burchall
Journal:  J Biol Chem       Date:  1979-07-25       Impact factor: 5.157

View more
  8 in total

Review 1.  Trimethoprim resistance.

Authors:  P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

2.  Possible role of insertion sequence IS257 in dissemination and expression of high- and low-level trimethoprim resistance in staphylococci.

Authors:  A Leelaporn; N Firth; M E Byrne; E Roper; R A Skurray
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

3.  Pathogenic Nocardia cyriacigeorgica and Nocardia nova Evolve To Resist Trimethoprim-Sulfamethoxazole by both Expected and Unexpected Pathways.

Authors:  H Mehta; J Weng; A Prater; R A L Elworth; X Han; Y Shamoo
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

4.  Molecular characterization of trimethoprim resistance in Shigella sonnei in Sicily.

Authors:  A Agodi; C Jones; E J Threlfall; M D'Angelo; M Marranzano
Journal:  Epidemiol Infect       Date:  1990-08       Impact factor: 2.451

5.  Sequence identity with type VIII and association with IS176 of type IIIc dihydrofolate reductase from Shigella sonnei.

Authors:  N L Barg; S Register; C Thomson; S Amyes
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  Genomic, biochemical and microbial evaluation of probiotic potentials of bacterial isolates from fermented sorghum products.

Authors:  Ahmed Adebisi Otunba; Akinniyi Adediran Osuntoki; Daniel Kolawole Olukoya; Benjamin Ayodipupo Babalola
Journal:  Heliyon       Date:  2021-12-02

7.  Draft Genome Sequence of a Multiple Antibiotic Resistant Staphylococcus aureus NCTC 6571-UB Laboratory Strain.

Authors:  Paul Norton; Kah-Ooi Chua; Maria Katsikogianni; M Julie Thornton; Kok-Gan Chan; Chien-Yi Chang
Journal:  Microbiol Resour Announc       Date:  2022-08-23

8.  Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cryptotanshinone.

Authors:  Haihua Feng; Hua Xiang; Jiyu Zhang; Guowen Liu; Na Guo; Xuelin Wang; Xiuping Wu; Xuming Deng; Lu Yu
Journal:  J Biomed Biotechnol       Date:  2009-08-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.